Grant of Interim Extension of the Term of U.S. Patent No. 7,534,790; Vernakalant Hydrochloride, 10251 [2021-03427]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices
Act. The marking of fishing gear is also
valuable in actions concerning damage,
loss, and civil proceedings. The
requirements imposed in the U.S.
southeast region are for aquacultured
live rock; golden crab traps; spiny
lobster traps; black sea bass pots;
Spanish mackerel gillnets; and buoy
gear.
should be aware that your entire
comment, including your personal
identifying information, may be made
publicly available at any time. While
you may ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
II. Method of Collection
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
Markings, such as numbers, are
placed directly on fishing vessels and
gear.
[FR Doc. 2021–03366 Filed 2–18–21; 8:45 am]
III. Data
BILLING CODE 3510–22–P
OMB Control Number: 0648–0358.
Form Number(s): None.
Type of Review: Regular submission
(extension of a current information
collection).
Affected Public: Business or other forprofit organizations.
Estimated Number of Respondents:
7,825.
Estimated Time per Response: Vessel
marking: 75 minutes. Gear marking:
Aquacultured live rocks, 10 seconds
each; golden crab traps, 2 minutes each;
spiny lobster traps, 7 minutes each; sea
bass pots, 16 minutes each; and Spanish
mackerel gillnets, 20 minutes each; and
buoy gear, 10 minutes each.
Estimated Total Annual Burden
Hours: 51,070.
Estimated Total Annual Cost to
Public: $673,277 in recordkeeping and
reporting costs.
Respondent’s Obligation: Mandatory.
Legal Authority: Magnuson-Stevens
Act, 16 U.S.C. 1801 et seq.
tkelley on DSKBCP9HB2PROD with NOTICES
IV. Request for Comments
We are soliciting public comments to:
(a) Evaluate whether the proposed
information collection is necessary for
the proper functions of the Department,
including whether the information will
have practical utility; (b) Evaluate the
accuracy of our estimate of the time and
cost burden for this proposed collection,
including the validity of the
methodology and assumptions used; (c)
Evaluate ways to enhance the quality,
utility, and clarity of the information to
be collected; and (d) Minimize the
reporting burden on those who are to
respond, including the use of automated
collection techniques or other forms of
information technology.
Comments that you submit in
response to this notice are a matter of
public record. We will include or
summarize each comment in our request
to OMB to approve this information
collection request. Before including
your address, phone number, email
address, or other personal identifying
information in your comment, you
VerDate Sep<11>2014
21:07 Feb 18, 2021
Jkt 253001
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No.: PTO–P–2021–0009]
Grant of Interim Extension of the Term
of U.S. Patent No. 7,534,790;
Vernakalant Hydrochloride
United States Patent and
Trademark Office, Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:
The United States Patent and
Trademark Office has issued an order
granting interim extension for a oneyear interim extension of the term of
U.S. Patent No. 7,534,790.
FOR FURTHER INFORMATION CONTACT: Raul
Tamayo by telephone at 571–272–7728;
by mail marked to his attention and
addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to his attention at
571–273–7728; or by email to
raul.tamayo@uspto.gov.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent. On February 9, 2021, Correvio
International Sa`rl, the patent owner of
record, timely filed an application
under 35 U.S.C. 156(d)(5) for a third
interim extension of the term of U.S.
Patent No. 7,534,790. The patent claims
the human drug product vernakalant
hydrochloride. The application for
patent term extension indicates that
New Drug Application (NDA) 22–034
was submitted to the Food and Drug
SUMMARY:
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
10251
Administration (FDA) on December 19,
2006.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the twiceextended expiration date of the patent,
March 31, 2021, interim extension of the
patent term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
7,534,790 is granted for a period of one
year from the extended expiration date
of the patent.
Robert Bahr,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
[FR Doc. 2021–03427 Filed 2–18–21; 8:45 am]
BILLING CODE 3510–16–P
COMMODITY FUTURES TRADING
COMMISSION
Global Markets Advisory Committee
Commodity Futures Trading
Commission.
ACTION: Notice of meeting.
AGENCY:
The Commodity Futures
Trading Commission (CFTC) announces
that on March 11, 2021, from 9:00 a.m.
to 1:00 p.m. (Eastern Standard Time),
the Global Markets Advisory Committee
(GMAC) will hold a public meeting via
teleconference. At this meeting, the
GMAC will continue discussions on the
impact of market volatility related to the
coronavirus pandemic and recent effects
on international central counterparties
and the global clearing ecosystem; and
hear presentations and provide dialogue
on matters related to retail participation
in the derivatives markets.
DATES: The meeting will be held on
March 11, 2021, from 9:00 a.m. to 1:00
p.m. (Eastern Standard Time). Members
of the public who wish to submit
written statements in connection with
the meeting should submit them by
March 18, 2021.
ADDRESSES: The meeting will take place
via teleconference. You may submit
public comments, identified by ‘‘Global
Markets Advisory Committee,’’ via the
CFTC’s website, https://
comments.cftc.gov. If you are unable to
submit comments via the CFTC’s
website, contact Andre´e Goldsmith,
SUMMARY:
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Page 10251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03427]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No.: PTO-P-2021-0009]
Grant of Interim Extension of the Term of U.S. Patent No.
7,534,790; Vernakalant Hydrochloride
AGENCY: United States Patent and Trademark Office, Commerce.
ACTION: Notice of interim patent term extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued an
order granting interim extension for a one-year interim extension of
the term of U.S. Patent No. 7,534,790.
FOR FURTHER INFORMATION CONTACT: Raul Tamayo by telephone at 571-272-
7728; by mail marked to his attention and addressed to the Commissioner
for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA
22313-1450; by fax marked to his attention at 571-273-7728; or by email
to [email protected].
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of up to five years if the patent claims a product, or a method
of making or using a product, that has been subject to certain defined
regulatory review, and that the patent may be extended for interim
periods of up to one year if the regulatory review is anticipated to
extend beyond the expiration date of the patent. On February 9, 2021,
Correvio International S[agrave]rl, the patent owner of record, timely
filed an application under 35 U.S.C. 156(d)(5) for a third interim
extension of the term of U.S. Patent No. 7,534,790. The patent claims
the human drug product vernakalant hydrochloride. The application for
patent term extension indicates that New Drug Application (NDA) 22-034
was submitted to the Food and Drug Administration (FDA) on December 19,
2006.
Review of the patent term extension application indicates that,
except for permission to market or use the product commercially, the
subject patent would be eligible for an extension of the patent term
under 35 U.S.C. 156, and that the patent should be extended for one
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory
review period will continue beyond the twice-extended expiration date
of the patent, March 31, 2021, interim extension of the patent term
under 35 U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S.
Patent No. 7,534,790 is granted for a period of one year from the
extended expiration date of the patent.
Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent
and Trademark Office.
[FR Doc. 2021-03427 Filed 2-18-21; 8:45 am]
BILLING CODE 3510-16-P
